Robert E. Smith

Liberty University — United States

Medicine · Health Sciences

60h-index14.1kcitations416works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adipose Tissue and Metabolism(16), Pharmaceutical Practices and Patient Outcomes(15), Animal Nutrition and Physiology(13), Analytical Chemistry and Chromatography(13), Erythropoietin and Anemia Treatment(13)

Publications414 total

Atypical Presentation of Metastatic Breast Cancer: Gastric Outlet Obstruction and Linitis Plastica
Cureus·2025Open Access
Role of Insulin Signaling in Prostaglandins Synthesis
Translation The University of Toledo Journal of Medical Sciences·2024Open Access
Abstract P5-02-43: Incidence of HER2-low Expression in HR-positive/HER2-negative and Triple-Negative Breast Cancers in the Integra Connect Database
Cancer Research·2023
Fluorescence method for enzyme analysis which couples aromatic amines with aromatic aldehydes
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2023Open Access
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States
Expert Review of Hematology·2022· 7 cited
Quality initiative (QI) to improve molecular testing in newly diagnosed (ND) stage 4 non-small cell lung cancer (NSCLC-4): An Integra Connect (IC) database study.
Journal of Clinical Oncology·2022
Phytochemical Analysis of the Fruit Pulp Extracts from Annona crassiflora Mart. and Evaluation of Their Antioxidant and Antiproliferative Activities
Foods·2022· 23 citedOpen Access
Quality initiative (QI) to improve molecular testing in newly diagnosed (ND) stage 4 non-small cell lung cancer (NSCLC-4): An Integra Connect (IC) database study.
Journal of Clinical Oncology·2022
Impact of turnaround time (TAT) of molecular testing on initial treatment (Tx) in newly diagnosed stage 4 non-small cell lung cancer (NSCLC 4): An Integra Connect (IC) retrospective observational study.
Journal of Clinical Oncology·2022· 3 cited
Evaluation of outcomes in patients (pts) with stage 4 non-small cell lung cancer (NSCLC 4) harboring actionable oncogenic drivers (AOD) when treated prior to report of mutation without tyrosine kinase inhibitors (TKI): An Integra Connect Database (ICD) retrospective observational study.
Journal of Clinical Oncology·2022· 4 cited
Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014–2018)
Clinical Infectious Diseases·2022· 2 cited
Daratumumab Utilization and Cost Analysis among Patients with Multiple Myeloma in a US Community Oncology Setting
Future Oncology·2021· 10 citedOpen Access
Quality initiative (QI) in unresectable stage III non-small cell lung cancer (NCSLC): Impact on time-to-treatment (TTT) for immunotherapy post chemoradiation (CRT).
Journal of Clinical Oncology·2021
The impact of COVID-19 pandemic on access to new patient cancer care as evaluated in the Integra Connect Database (ICD).
Journal of Clinical Oncology·2021
The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011–2017
Clinical Infectious Diseases·2021· 8 citedOpen Access
Daratumumab Dose Analysis Among Patients with Multiple Myeloma in a US Community Oncology Setting: A Retrospective Observational Study in Integra Connect Network
Blood·2020
Annonacin and Squamocin Contents of Pawpaw (Asimina triloba) and Marolo (Annona crassiflora) Fruits and Atemoya (A. squamosa × A. cherimola) Seeds
Biological Trace Element Research·2020· 6 cited
Udenyca has equivalent efficacy to the pegfilgrastim originator in breast cancer patients receiving highly myelosuppressive chemotherapy.
Journal of Clinical Oncology·2020· 3 cited
Cost savings of biosimilar pegfilgrastim in a Medicare OCM population.
Journal of Clinical Oncology·2020· 5 cited
A retrospective three-year analysis using real-world data on uptake of broad-based NextGen sequencing panels in community oncology practices.
Journal of Clinical Oncology·2020· 5 cited
page 1 of 21Next →

Frequent Co-authors

Scott D. Holmberg(4), Loralee B. Rupp(4), Anne C. Moorman(4), John A. Glaspy(3), James H. Meador‐Woodruff(3), Lois Lamerato(3), Vinutha Vijayadeva(3), Joseph A. Boscarino(3), Stuart C. Gordon(3), Henning T. Mouridsen(2), Mikhail Gershanovich(2), Yan Sun(2), R. Pérez-Carrión(2), C. Boni(2), Alain Monnier(2), Justus Apffelstaedt(2), H.P. Sleeboom(2), A Płużańska(2), Magdolna Dank(2), D. Becquart(2)